View in EDS

PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate.

Saved in:
Bibliographic Details
Title: PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate.
Authors: Lin, D.1 (AUTHOR), Morrison, L.2 (AUTHOR), Pilon, D.3 (AUTHOR), Benson, C.4 (AUTHOR), Ghelerter, I.2 (AUTHOR), Vermette-Laforme, M.3 (AUTHOR), Lefebvre, P.3 (AUTHOR)
Source: Value in Health. 2021 Supplement 1, Vol. 24, pS129-S129. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2021.04.630